Company Filing History:
Years Active: 2022-2025
Title: Shibeshih Mitiku Belachew: Innovator in Digital Qualimetric Biomarkers
Introduction
Shibeshih Mitiku Belachew is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of digital qualimetric biomarkers, particularly in assessing cognition and movement diseases or disorders. With a total of 3 patents, his work is paving the way for innovative solutions in healthcare.
Latest Patents
Belachew's latest patents include groundbreaking methods for assessing cognition and movement diseases. One of his patents focuses on digital qualimetric biomarkers for cognition and movement diseases or disorders. This method involves determining a qualimetric activity parameter from a dataset obtained through a mobile device. The parameter is then compared to a reference to assess the disease or disorder. Additionally, he has developed a method to identify whether a subject will benefit from therapy for these conditions, utilizing mobile technology.
Another significant patent by Belachew is related to determining information processing speed. This method assesses a test subject's cognitive capabilities by comparing various qualimetric activity parameters. The results can help identify cognitive impairments based on the subject's processing speed, showcasing the potential for computer-implemented solutions in this area.
Career Highlights
Shibeshih Mitiku Belachew is currently employed at Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work there focuses on leveraging technology to improve patient outcomes through innovative assessment methods.
Collaborations
Belachew collaborates with talented professionals in his field, including Mike Baker and Christian Gossens. These partnerships enhance the development and implementation of his innovative ideas.
Conclusion
Shibeshih Mitiku Belachew is a pioneering inventor whose work in digital qualimetric biomarkers is transforming the assessment of cognition and movement diseases. His contributions are vital for advancing healthcare technology and improving patient care.